Graham Capital Management, L.P. United Therapeutics Corp Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$210.76 - $249.51 $122,240 - $144,715
-580 Reduced 12.35%
4,116 $945,000
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $622,937 - $744,869
2,899 Added 161.32%
4,696 $1.03 Million
Q3 2023

Nov 22, 2023
BUY
$211.82 - $248.24 $380,640 - $446,087
1,797 New
1,797 $405,000
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $1.35 Million - $1.62 Million
6,634 New
6,634 $1.39 Million

Others Institutions Holding UTHR

# of Institutions
669
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email